Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes
- 13 March 2006
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 190 (2) , 359-369
- https://doi.org/10.1016/j.atherosclerosis.2006.02.007
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodiesJournal of Lipid Research, 2004
- Associations among oxidized low-density lipoprotein antibody, C-reactive protein, interleukin-6, and circulating cell adhesion molecules in patients with unstable angina pectorisThe American Journal of Cardiology, 2004
- Lipoprotein AutoantibodiesClinical and Vaccine Immunology, 2003
- Autoimmune response to advanced glycosylation end-products of human LDLJournal of Lipid Research, 2003
- Autoantibodies Against Oxidized Low-Density Lipoprotein and Cardiolipin in Patients With Coronary Heart DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Modification of Lipoproteins in DiabetesDiabetes/Metabolism Research and Reviews, 1996
- Diagnostic value of immune cholesterol as a marker for atherosclerosisJournal of Cardiovascular Risk, 1995
- Diagnostic Value of Immune Cholesterol as a Marker for AtherosclerosisEuropean Journal of Preventive Cardiology, 1995
- Activation of Human Monocyte-Derived Macrophages by Immune Complexes Containing Low-Density LipoproteinClinical Immunology and Immunopathology, 1995
- Patients With Early-Onset Peripheral Vascular Disease Have Increased Levels of Autoantibodies Against Oxidized LDLArteriosclerosis, Thrombosis, and Vascular Biology, 1995